Diving Into The Future Of Therapeutic Apheresis: An Interview With Dr. Dobri Kiprov

In this episode, we connect with Dr. Dobri Kiprov, an internationally renowned pioneer and expert in Therapeutic Apheresis, immunotherapy, long-term COVID-19, and age-related disorders. As the founder and president of Global Apheresis, Inc., Dr. Kiprov brings more than 30 years of experience to the field of Therapeutic Apheresis – the process of separating the cellular and soluble components of blood using a machine.

Dr. Kiprov served two terms on the American Society for Apheresis (ASFA) board of directors and created its first educational video program. Additionally, he was the first physician to take and pass the Hemapheresis Practitioner Exam (ASCP). Want to learn more about Dr. Kiprov’s groundbreaking work and his contributions to the field of apheresis? Tune in to this episode for an in-depth conversation…

Jump in now to discover:

• What therapeutic plasma exchange is, and its impact on the physical state of blood.
• Scenarios where plasma removal and replacement offer significant benefits.
• The journey of plasma from removal to its eventual processing.

To find out more about Dr. Kiprov, click here now!

Episode also available on Apple Podcasts: http://apple.co/30PvU9

Podcast: Play in new window | Download | Embed